Inventor · disambiguated record
Joseph Bryant
Also filed as: BRYANT JOSEPH · BRYANT JOSEPH L
22 granted patents·2 pending applications·859 citations·filing 1994–2017
96Inventor score
Top patents by PatentIndex Score
24 records- 0197US6620416B1Method for treating HIVUNIV MARYLAND BIOTECH INST·Filed 2000·Granted Sep 16, 2003·63 cites·103 claims
- 0297US6596688B1Method for promoting hematopoiesisUNIV MARYLAND BIOTECH INST·Filed 2000·Granted Jul 22, 2003·62 cites·120 claims
- 0394US6583109B1Therapeutic polypeptides from β-hCG and derivativesFiled 1998·Granted Jun 24, 2003·104 cites·102 claims
- 0493US6699656B2Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropinUNIV MARYLAND BIOTECH INST·Filed 2001·Granted Mar 2, 2004·38 cites·5 claims
- 0591US5677275ATreatment of cancer with human chorionic gonadotropinUS HEALTH·Filed 1994·Granted Oct 14, 1997·82 cites·7 claims
- 0690US6156952AHIV transgenic animals and uses thereforUNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE·Filed 1998·Granted Dec 5, 2000·104 cites·13 claims
- 0790US5968513AMethod of promoting hematopoiesis using derivatives of human chorionic gonadotropinUNIV MARYLAND BIOTECH INST·Filed 1996·Granted Oct 19, 1999·108 cites·104 claims
- 0889US9175077B2Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)GALLO ROBERT C·Filed 2011·Granted Nov 3, 2015·7 cites·4 claims
- 0988US9687469B2Agent containing flavonoid derivatives for treating cancer and inflammationLOWE HENRY·Filed 2015·Granted Jun 27, 2017·5 cites·1 claims
- 1088US5997871ATreatment and prevention of cancer by administration of derivatives of human chorionic gonadotropinUNIV MARYLAND BIOTECH INST·Filed 1996·Granted Dec 7, 1999·83 cites·38 claims
- 1188US5877148ATreatment of cancer with human chorionic gonadotropinUS HEALTH·Filed 1997·Granted Mar 2, 1999·77 cites·16 claims
- 1285US6319504B1Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropinUNIV MARYLAND BIOTECH INST·Filed 1996·Granted Nov 20, 2001·65 cites·122 claims
- 1381US8715748B2Methods for inhibiting prostate cancer by kinases and angiogenesis inhibitory mechanisms of ball moss extractLOWE HENRY·Filed 2013·Granted May 6, 2014·2 cites·5 claims
- 1480US5770563AHeparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereofUS HEALTH·Filed 1995·Granted Jun 23, 1998·52 cites·41 claims
- 1579US6805882B1Therapeutic fractions of sources of HCGUNIV MARYLAND BIOTECH INST·Filed 2000·Granted Oct 19, 2004·3 cites·14 claims
- 1679US6699834B1Method for treating cancerUNIV MARYLAND BIOTECH INST·Filed 2000·Granted Mar 2, 2004·3 cites·114 claims
- 1776US10765660B2Agent containing flavonoid derivatives for treating cancer and inflammationLOWE HENRY·Filed 2017·Granted Sep 8, 2020·1 cites·7 claims
- 1868US9040100B2Methods for inhibiting prostate cancer by kinases and angiogenesis inhibitory mechanisms of ball moss extractLOWE HENRY·Filed 2014·Granted May 26, 2015·0 cites·1 claims
- 1959US2014148582A1Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (ma)NOBEL BIOSCIENCES LLC·Filed 2013·Application pending·0 cites
- 2050US6660904B1HIV and CD4 transgenic animals and uses thereforUNIV MARYLAND BIOTECH INST·Filed 2000·Granted Dec 9, 2003·0 cites·9 claims
- 2148US8907117B2Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analoguesLOWE HENRY·Filed 2012·Granted Dec 9, 2014·0 cites·1 claims
- 2245US2004177393A1HIV and CD4 transgenic animals and uses thereforFiled 2003·Application pending·0 cites
- 2344US7994278B1Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)NOBEL BIOSCIENCES LLC·Filed 2000·Granted Aug 9, 2011·0 cites·20 claims
- 2442US9814747B2Methods for inhibiting HIV-1 activity by inhibitory mechanisms of extracts of Guaiacum officinale L. (zygophyllaceae)LOWE HENRY·Filed 2015·Granted Nov 14, 2017·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →